The Univeristy of Melbourne The Royal Melbourne Hopspital

A joint venture between The University of Melbourne and The Royal Melbourne Hospital


Research Projects

Project: SARS-CoV-2 immunity with time and age

Valkenburg group

The COVID-19 pandemic by the novel SARS-CoV-2 virus has caused incalculable loss. The majority of infections are asymptomatic especially in children yet the underlying immune mechanism is unknown. Mild or asymptomatic infections can result in lower magnitude immune responses which may leave an individual susceptible to reinfection. The early recruitment kinetics of cellular responses is important for establishing long term immune memory. SARS-CoV-2 specific immunity will be probed in children, asymptomatic cases, longitudinal long term responses and following vaccination. Human studies will be complemented with next generation broadly reactive vaccines in animal models to address issues of variants of concern.

Contact project supervisor for further
information and application enquiries

Project Supervisor

Dr Sophie Valkenburg

Project Co-supervisor

Professor Katherine Kedzierska

Project availability
Master of Biomedical Science

Valkenburg group

2 vacancies

Cross Cutting Disciplines

The Valkenburg laboratory investigates viral immunity to emerging viruses with pandemic potential: influenza viruses and SARS-CoV-2. Her work spans randomized control vaccine trials, observational studies of infected patients and animal models to decipher immune correlates to drive novel translational outcomes for specific diagnostics, targeted therapeutics and next generation vaccines for public health impact.

Valkenburg group Current Projects